Comments

LAVA Therapeutics

LVTXNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$2.04
0.020.99%
At Close: -
$2.27
0.2311.27%
After Hours: 7:34 PM EDT
15 minutes delayed
LAVA Therapeutics (LVTX) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$28.00
Lowest Price Target1
$6.00
Consensus Price Target1
$12.25

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

LAVA Therapeutics (NASDAQ:LVTX) Stock, Analyst Ratings, Price Targets, Forecasts

LAVA Therapeutics NV has a consensus price target of $12.25 based on the ratings of 4 analysts. The high is $28 issued by SVB Leerink on September 27, 2022. The low is $6 issued by HC Wainwright & Co. on June 28, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on June 28, 2024, March 21, 2024, and November 17, 2023, respectively. With an average price target of $6 between HC Wainwright & Co., there's an implied 164.32% upside for LAVA Therapeutics NV from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
0
0
0
0
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
JMP Securities
HC Wainwright & Co.
SVB Leerink

1calculated from analyst ratings

Analyst Ratings for LAVA Therapeutics

Buy NowGet Alert
06/28/2024Buy Now164.32%HC Wainwright & Co.
Arthur He
$6 → $6ReiteratesBuy → BuyGet Alert
03/21/2024Buy Now164.32%HC Wainwright & Co.
Arthur He
 → $6ReiteratesBuy → BuyGet Alert
11/17/2023Buy Now164.32%HC Wainwright & Co.
Arthur He
 → $6ReiteratesBuy → BuyGet Alert
08/23/2023Buy Now164.32%JMP Securities
Reni Benjamin
 → $6ReiteratesMarket Outperform → Market OutperformGet Alert
08/23/2023Buy Now164.32%HC Wainwright & Co.
Arthur He
$9 → $6MaintainsBuyGet Alert
06/15/2023Buy Now164.32%JMP Securities
Reni Benjamin
 → $6ReiteratesMarket Outperform → Market OutperformGet Alert
06/12/2023Buy Now296.48%HC Wainwright & Co.
Arthur He
 → $9ReiteratesBuy → BuyGet Alert
06/09/2023Buy Now164.32%JMP Securities
Reni Benjamin
 → $6ReiteratesMarket Outperform → Market OutperformGet Alert
04/13/2023Buy Now296.48%HC Wainwright & Co.
Arthur He
 → $9Reiterates → BuyGet Alert
02/17/2023Buy Now296.48%HC Wainwright & Co.
Swayampakula Ramakanth
 → $9Reiterates → BuyGet Alert
10/25/2022Buy Now296.48%HC Wainwright & Co.
Arthur He
 → $9Initiates → BuyGet Alert
09/27/2022Buy Now1133.48%SVB Leerink
Daina Graybosch
$25 → $28MaintainsOutperformGet Alert
09/15/2022Buy Now164.32%JMP Securities
Reni Benjamin
 → $6Initiates → Market OutperformGet Alert
05/18/2022Buy Now1001.32%SVB Leerink
Daina Graybosch
$23 → $25MaintainsOutperformGet Alert
11/16/2021Buy Now781.06%SVB Leerink
Daina Graybosch
—MaintainsOutperformGet Alert
08/17/2021Buy Now957.27%SVB Leerink
Daina Graybosch
—MaintainsOutperformGet Alert

FAQ

Q

What is the target price for LAVA Therapeutics (LVTX) stock?

A

The latest price target for LAVA Therapeutics (NASDAQ:LVTX) was reported by HC Wainwright & Co. on June 28, 2024. The analyst firm set a price target for $6.00 expecting LVTX to rise to within 12 months (a possible 164.32% upside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for LAVA Therapeutics (LVTX)?

A

The latest analyst rating for LAVA Therapeutics (NASDAQ:LVTX) was provided by HC Wainwright & Co., and LAVA Therapeutics reiterated their buy rating.

Q

When was the last upgrade for LAVA Therapeutics (LVTX)?

A

There is no last upgrade for LAVA Therapeutics

Q

When was the last downgrade for LAVA Therapeutics (LVTX)?

A

There is no last downgrade for LAVA Therapeutics.

Q

When is the next analyst rating going to be posted or updated for LAVA Therapeutics (LVTX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LAVA Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LAVA Therapeutics was filed on June 28, 2024 so you should expect the next rating to be made available sometime around June 28, 2025.

Q

Is the Analyst Rating LAVA Therapeutics (LVTX) correct?

A

While ratings are subjective and will change, the latest LAVA Therapeutics (LVTX) rating was a reiterated with a price target of $6.00 to $6.00. The current price LAVA Therapeutics (LVTX) is trading at is $2.27, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.